山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (4): 5-10.doi: 10.6040/j.issn.1673-3770.1.2020.048

• 眼缺血综合征多学科精准诊疗 专家笔谈 • 上一篇    下一篇

溶栓治疗在视网膜动脉阻塞中的应用进展

杨明综述魏文斌审校   

  1. 杨明 综述 魏文斌 审校 首都医科大学附属北京同仁医院/北京同仁眼科中心/眼内肿瘤诊治研究北京市重点实验室/北京市眼科学与视觉科学重点实验室/医学人工智能研究与验证工信部重点实验室, 北京 100730
  • 收稿日期:2019-05-26 出版日期:2020-07-20 发布日期:2020-08-28
  • 基金资助:
    国家自然科学基金(81570891);北京市自然科学基金(7151003);北京市医院管理局“登峰”人才培养计划(DFL20150201);北京市卫生系统高层次卫生技术人才培养计划(2014-2-003);首都卫生发展科研专项(首发2016-1-2051);北京市医院管理局临床医学发展专项经费资助(扬帆计划)(ZYLX201307);北京市科委科技计划项目(Z181100001818003,Z151100001615052)

Application progress of thrombolysis in retinal artery occlusionYANG Ming Overview WEI Wenbin Guidance Beijing Tongren Hospital, Capital Medical University / Beijing Tongren Eye Center / Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment / Beijing Ophthalmology&Visual Sciences Key Lab / Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing 100730, ChinaAbstract:

Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application.   

  1. Key words: Thrombolysis;
    Retinal artery occlusion/therapy;
    Arterial thrombolysis;
    Intravenous thrombolysis视网膜动脉阻塞是类似于脑卒中的临床眼科急症, 其发病原因可能是栓子栓塞、血栓形成、动脉痉挛及受压等, 每年发病率约1/100 000［1］, 临床表现为突发单眼无痛的视觉丧失, 如果不及时进行临床干预, 约80%的患者进展到视力为20/400或更低［2］, RAO最常见的原因是栓子栓塞视网膜动脉, 溶栓治疗即激发纤溶系统, 将包裹于原发性栓子的血性栓塞物及单纯性血栓溶解而使栓子变小甚至消失, 最大减少缺血受损范围［3］, 既往的研究表明, 视力恢复的程度往往与发生视网膜缺血的总时间相关。Hayreh等［4］报道, 当视网膜缺血时间超过4 h, 视网膜组织RGC细胞会发生不可逆的形态学变化, 随着缺血时间增加, 视功能及神经组织的损害更严重。
  • Received:2019-05-26 Online:2020-07-20 Published:2020-08-28

PDF (PC)

428

摘要： 视网膜动脉阻塞是引起急性视力下降的眼科常见疾病, 溶栓治疗属于相对于保守治疗外较激进的治疗方法, 包括动脉溶栓和静脉溶栓, 以及溶栓与其他疗法的联合治疗, 溶栓治疗虽能提高患者视力, 但是因为其并存的风险以及缺少大样本前瞻随机对照研究而一直不能为临床提供有力的证据, 综述近十年国内外关于溶栓治疗的研究进展, 进一步评估其安全性和有效性, 为临床应用提供理论依据。

关键词: 溶栓治疗, 视网膜动脉阻塞, 动脉溶栓, 静脉溶栓

Abstract: Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application.

Key words: Thrombolysis, Retinal artery occlusion/therapy, Arterial thrombolysis, Intravenous thrombolysis

中图分类号: 

  • R765.21
[1] Leavitt JA, Larson TA, Hodge DO, et al. The incidence of central retinal artery occlusion in Olmsted County, Minnesota[J]. Am J Ophthalmol, 2011, 152(5): 820-823.e2. doi:10.1016/j.ajo.2011.05.005.
[2] Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome[J]. Am J Ophthalmol, 2005, 140(3): 376-391. doi:10.1016/j.ajo.2005.03.038.
[3] Hayreh SS. Acute retinal arterial occlusive disorders[J]. Prog Retin Eye Res, 2011, 30(5): 359-394. doi:10.1016/j.preteyeres.2011.05.001.
[4] Hayreh SS, Zimmerman M, Kimura A, et al. Central retinal artery occlusion[J]. Exp Eye Res, 2004, 78(3): 723-736. doi:10.1016/s0014-4835(03)00214-8.
[5] Brinster CJ, Sternbergh WC 3rd. Safety of urgent carotid endarterectomy following thrombolysis[J]. J Cardiovasc Surg(Torino), 2020, 61(2): 149-158. doi:10.23736/S0021-9509.20.11179-0.
[6] Margolin EA, Rai A, Goldfarb J, et al. Dramatic recovery of vision in patient with acute central retinal artery occlusion treated with local intra-arterial tissue plasminogen activator[J]. BMJ Case Rep, 2020, 13(4): e234505. doi:10.1136/bcr-2020-234505.
[7] Schorr EM, Rossi KC, Stein LK, et al. Characteristics and outcomes of retinal artery occlusion: nationally representative data[J]. Stroke, 2020, 51(3): 800-807. doi:10.1161/STROKEAHA.119.027034.
[8] Schumacher M, Schmidt D, Jurklies B, et al. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial[J]. Ophthalmology, 2010, 117(7): 1367-1375.e1. doi:10.1016/j.ophtha.2010.03.061.
[9] Hayreh SS. Comment re: multicenter study of the european assessment group for lysis in the eye(EAGLE)for the treatment of central retinal artery occlusion: design issues and implications[J]. Graefes Arch Clin Exp Ophthalmol, 2007, 245(3): 464-466. doi: 10.1007/s00417-006-0473-5.
[10] 罗茂梅, 蔡善君. 血栓溶解法治疗视网膜中央动脉阻塞[J]. 国际眼科纵览, 2018(6): 406-409. doi: 10.3760/cma.j.issn.1673-5803.2018.06.010. LUO Maomei, CAI Shanjun. Thrombolysis for central retinal artery occlusion[J]. International Review of Opthalmology, 2018(6): 406-409. doi: 10.3760/cma.j.issn.1673-5803.2018.06.010.
[11] 朱爱玲. 视网膜动脉阻塞的治疗新进展[J]. 国外医学(眼科学分册), 1997(2): 90-93.
[12] 陈嘉宝, 李金瑛. 视网膜动脉阻塞治疗现状[J]. 国际眼科纵览, 2019, 043(001): 68-72. doi: 10.3760/cma.j.issn.1673-5803.2019.01.014.
[13] 昊晓云, 李国培, 何耀强, 等. 超选择性眼动脉插管溶栓治疗视网膜中央动脉阻塞[J]. 现代诊断与治疗, 2016, 27(14): 2572-2573. WU Xiaoyun, LI Guopei, HE Yaoqiang, et al. Observation of the effect of super selective ophthalmic artery catheterization in the treatment of central retinal artery occlusion[J]. Mod Diagn Treat, 2016, 27(14): 2572-2573.
[14] 郭丽, 吴航, 吉训明, 等. 超选择眼动脉溶栓介入治疗视网膜中央动脉阻塞[J]. 眼科, 2007, 16(4):246-249. doi: 10.3969/j.issn.1004-4469.2007.04.009. GUO Li, WU Hang, JI Xunming, et al. Thrombolysis infusion via super selective ophthalmic artery catheterization treating central retinal artery occlusion[J]. Ophthalmology in China, 2007, 16(4):246-249. doi: 10.3969/j.issn.1004-4469.2007.04.009.
[15] Mercier J, Kastler A, Jean B, et al. Interest of local intra-arterial fibrinolysis in acute central retinal artery occlusion: Clinical experience in 16 patients[J]. J De Neuroradiol, 2015, 42(4): 229-235. doi:10.1016/j.neurad.2014.02.007.
[16] 陈娟. 超选择性眼动脉溶栓治疗视网膜中央动脉栓塞40例疗效观察[J]. 医药前沿, 2018, 8(8): 224-225.
[17] Page PS, Khattar NK, White AC, et al. Intra-arterial thrombolysis for acute central retinal artery occlusion: a systematic review and meta-analysis[J]. Front Neurol, 2018, 9: 76. doi:10.3389/fneur.2018.00076.
[18] Aldrich EM, Lee AW, Chen CS, et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience[J]. Stroke, 2008, 39(6): 1746-1750. doi:10.1161/STROKEAHA.107.505404.
[19] Wang RS, Qian L, Wang Y, et al. Evaluation of ophthalmic artery branch retrograde intervention in the treatment of central retinal artery occlusion(CRAO)[J]. Med Sci Monit, 2017, 23: 114-120. doi:10.12659/msm.898352.
[20] 王润生, 钱路, 王毅, 等. 眼动脉分支逆行介入溶栓治疗视网膜中央动脉阻塞疗效观察[J]. 中华眼底病杂志, 2016, 32(4): 377-381. doi: 10.3760/cma.j.issn.1005-1015.2016.04.008. WANG Runsheng, QIAN Lu, WANG Yi, et al. Ophthalmic artery branch retrograde interventional therapy for central retinal artery occlusion[J]. Chinese Journal of Ocular Fundus Diseases, 2016, 32(4): 377-381. doi: 10.3760/cma.j.issn.1005-1015.2016.04.008.
[21] 雷涛, 王润生, 李豫, 等. 经滑车上动脉逆行或颈外动脉顺行介入溶栓治疗视网膜中央动脉阻塞伴同侧颈内动脉闭塞的疗效观察[J]. 中华眼底病杂志, 2018, 34(3):228-232. doi: 10.3760/cma.j.issn.1005-1015.2018.03.005. LEI Tao, WANG Runsheng, LI Yu, et al. The effect of interventional thrombolytic therapy for central retinal artery occlusion with ipsilateral internal carotid artery occlusion via supratrochlear artery retrogradely or external carotid artery anterogradely[J]. Chinese Journal of Ocular Fundus Diseases, 2018, 34(3):228-232. doi: 10.3760/cma.j.issn.1005-1015.2018.03.005.
[22] 张倩. 尿激酶静脉溶栓治疗视网膜中央动脉阻塞的临床效果观察[J]. 北方药学, 2019, 16(6): 139-140. doi: CNKI:SUN:BFYX.0.2019-06-112.
[23] Isayev Y, Conahan E, Mathiesen C, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients[J]. Neurology, 2010, 75: 1853-1854.
[24] Dumitrascu OM, Shen JF, Kurli M, et al. Is intravenous thrombolysis safe and effective in central retinal artery occlusion? A critically appraised topic[J]. Neurologist, 2017, 22(4): 153-156. doi:10.1097/NRL.000000000-0000129.
[25] Schultheiss M, Härtig F, Spitzer MS, et al. Intravenous thrombolysis in acute central retinal artery occlusion—A prospective interventional case series[J]. PLoS One, 2018, 13(5): e0198114. doi:10.1371/journal.pone.0198114.
[26] Biousse V, Calvetti O, Bruce BB, et al. Thrombolysis for central retinal artery occlusion[J]. J Neuro-Ophthalmol, 2007, 27(3): 215-230. doi:10.1097/WNO.0b013e31814b1f66.
[27] Wu XJ, Gao F, Liu X, et al. Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion[J]. Exp Ther Med, 2016, 12(4): 2617-2621. doi:10.3892/etm.2016.3681.
[28] 王润生, 吕沛霖, 张娅萍, 等. 以尿激酶静脉溶栓为主治疗视网膜中央动脉阻塞115例临床疗效观察[J].中华眼底病杂志, 2012, 28(5): 466-471. doi: 10.3760/cma.j.issn.1005-1015.2012.05.009. WANG Runsheng, LV Peilin, ZHANG Yaping, et al. Intravenous thrombolysis with urokinase for central retinal artery occlusion in 115 patients[J]. Chinese Journal of Ocular Fundus Diseases, 2012, 28(5): 466-471. doi: 10.3760/cma.j.issn.1005-1015.2012.05.009.
[29] Murphy-Lavoie H, Butler F, Hagan C. Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm[J]. Undersea Hyperb Med, 2012, 39(5): 943-953.
[30] WU Xiaodong, CHEN Shuangshuang, LI Shizun, et al. Oxygen therapy in patients with retinal artery occlusion: a meta-analysis[J]. PLoS ONE, 2018,13(8):e0202154. doi: 10.1371/journal.pone.0202154.
[31] Fernandes Tiago, Araújo Rui, Castro Pedro, et al. Acute phase treatment in central retinal artery occlusion: thrombolysis, hyperbaric oxygen therapy or both?[J]. Journal of Thrombosis and Thrombolysis, 2020. doi: 10.1007/s11239-020-02072-0.
[32] 王铭义, 刘永晟, 王峰, 等. 眼动脉置管溶栓治疗颈动脉支架成形术后视网膜中央动脉栓塞一例[J]. 中华放射学杂志, 2018, 52(9): 713-715. doi: 10.3760/cma.j.issn.1005?1201.2018.09.017.
[33] Ahn SJ, Kim JM, Hong JH, et al. Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion[J]. Invest Ophthalmol Vis Sci, 2013, 54(12): 7746-55. doi: 10.1167/iovs.13-12952.
[34] Zhang X, Ji X, Luo Y, et al. Intra-arterial thrombolysis for acute central retinal artery occlusion[J]. Neurological Research, 2009, 31(4): 385-389. doi: 10.1179/174313209X444008.
[35] Arnold M, Koerner U, Remonda L, et al. Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion[J]. J Neueol Neurosurg Psychiatry, 2005, 140(1): 196-199. doi: 10.1016/j.ajo.2005.05.004.
[36] 马志中, 李宝民, 窦洪亮, 等. 经眼动脉超选插管溶栓治疗视网膜中央动脉阻塞[J]. 中华眼科杂志, 1996, 32: 445-447. doi: 10.1088/0256-307X/13/9/013.
[37] 赵喜庆, 孟祥靖, 吉训明, 等. 经眼动脉超选插管溶栓治疗视网膜中央动脉阻塞[J]. 中华眼底病杂志, 2005, 21(1): 22-24. doi: 10.1088/0256-307X/13/9/013. ZHAO Qingxi, MENG Xiangjing, JI Xunming, et al. Treatment of central retinal artery occlusion by thrombolysis via super-selective ophthalmic artery catheterization[J]. Chinese Journal of Ocular Fundus Diseases, 2005, 21(1): 22-24. doi: 10.1088/0256-307X/13/9/013.
[38] Butz B, Strotzer M, Manke C, et al. Selective intraarterial fibrinolysis of acute central retinal artery occlusion[J]. Acta Radiologica, 2003, 44(6): 680-684. doi: 10.1046/j.1600-0455.2003.00147.x.
[39] Pettersen JA, Hill MD, Demchuk AM, et al. Intra-arterial thrombolysis for retinal artery occlusion: The Calgary experience[J]. Can J Neurol Sci, 2005, 32(4):507-511. doi: 10.1017/S0317167100004522.
[1] 陈曦,李珊珊,赵露,尤冉,王艳玲. 动脉溶栓治疗视网膜中央动脉阻塞Meta分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 28-34.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发